🐜
|
Role of CD146 (MCAM) in Physiological and Pathological Angiogenesis—Contribution of New Antibodies for Therapy
12 auth.
A. Joshkon,
X. Heim,
Cléa Dubrou,
R. Bachelier,
W. Traboulsi,
Jimmy Stalin,
...
H. Fayyad-kazan,
B. Badran,
A. Foucault-Bertaud,
A. Leroyer,
N. Bardin,
M. Blot-Chabaud
|
5 |
2020 |
5 🐜
|
🐜
|
CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases
11 auth.
X. Heim,
A. Joshkon,
J. Bermudez,
R. Bachelier,
Cléa Dubrou,
J. Boucraut,
...
A. Foucault-Bertaud,
A. Leroyer,
F. Dignat-George,
M. Blot-Chabaud,
N. Bardin
|
3 |
2020 |
3 🐜
|
🐜
|
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis
12 auth.
Roxane Claverie,
M. Perriguey,
A. Rico,
Clemence Boutiere,
S. Demortiere,
Pierre Durozard,
...
Frédéric Hilezian,
Cléa Dubrou,
F. Vely,
J. Pelletier,
B. Audoin,
A. Maarouf
|
3 |
2023 |
3 🐜
|
🐜
|
Persistent NK cell deficiency associated with pulmonary cryptococcosis
7 auth.
M. Martinot,
Shu Shun Li,
Catherine Farnarier,
Cléa Dubrou,
C. Pipéroglou,
Christopher H. Mody,
...
Frédéric Vély
|
2 |
2025 |
2 🐜
|
🐜
|
Deciphering the Reactivity of Autoantibodies Directed against the RNP-A, -C and 70 kDa Components of the U1-snRNP Complex: “Double or Nothing”?
7 auth.
D. Bertin,
Benjamin Babacci,
Alexandre Brodovitch,
Cléa Dubrou,
X. Heim,
J. Mège,
...
Nathalie Bardin
|
0 |
2024 |
0 🐜
|